BJERKHOLT ERIC
Insider CIK 1197350 · CERS Director · SNSS EVP, CFO & Corp. Secretary · KDNY Chief Financial Officer · GRAY Director · CORI Director · AIMT Chief Financial Officer · MIRM Chief Financial Officer · MGX Director · SRZN Director · STEM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-09-14 | 2026-09-15 | 9,943 | $98.37 | $978.1K | 44,745 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-09-14 | 2026-09-15 | 9,943 | $98.37 | $978.1K | 44,745 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-09-11 | 2026-09-15 | 18,333 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-09-11 | 2026-09-15 | 18,333 | — | $0 | 54,688 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-09-11 | 2026-09-15 | 18,333 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-09-11 | 2026-09-15 | 18,333 | — | — | 54,688 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-08-11 | 2026-08-12 | 6,001 | $99.90 | $599.5K | 36,355 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-08-11 | 2026-08-12 | 6,001 | $99.90 | $599.5K | 36,355 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-07-06 | 2026-07-08 | 3,124 | $121.67 | $380.1K | 44,057 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-07-06 | 2026-07-08 | 1,048 | $122.43 | $128.3K | 43,009 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-07-06 | 2026-07-08 | 528 | $123.84 | $65.4K | 42,481 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-07-06 | 2026-07-08 | 300 | $124.94 | $37.5K | 42,181 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-06-09 | 2026-06-09 | 2,393 | — | $0 | 26,653 | SEC↗ |
| MGX Metagenomi Therapeutics, I | A Award deriv | 2026-06-09 | 2026-06-11 | 21,000 | — | $0 | 21,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-06-09 | 2026-06-09 | 2,393 | $26.49 | $63.4K | 47,181 | SEC↗ |
| CERS CERUS CORP | S Sale | 2026-06-09 | 2026-06-11 | 20,454 | $2.60 | $53.2K | 261,679 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-06-08 | 2026-06-09 | 1,567 | $95.12 | $149.1K | 44,788 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-06-08 | 2026-06-09 | 2,258 | $92.84 | $209.6K | 47,530 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-06-08 | 2026-06-09 | 1,175 | $93.95 | $110.4K | 46,355 | SEC↗ |
| CERS CERUS CORP | A Award | 2026-06-02 | 2026-06-02 | 60,000 | — | $0 | 282,133 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award deriv | 2026-05-13 | 2026-05-14 | 5,550 | — | $0 | 5,550 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-03-16 | 2026-03-17 | 7,287 | $91.98 | $670.3K | 49,788 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-03-15 | 2026-03-17 | 13,334 | — | $0 | 6,666 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-03-15 | 2026-03-17 | 13,334 | — | $0 | 57,075 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-01-28 | 2026-01-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-01-28 | 2026-01-30 | 11,760 | — | $0 | 11,760 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-01-28 | 2026-01-30 | 18,140 | — | $0 | 18,140 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-01-26 | 2026-01-27 | 1,053 | $96.19 | $101.3K | 43,741 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-01-23 | 2026-01-27 | 2,667 | — | $0 | 2,666 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-01-23 | 2026-01-27 | 2,667 | — | $0 | 44,794 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-01-22 | 2026-01-23 | 1,421 | $93.33 | $132.6K | 42,127 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-01-21 | 2026-01-23 | 3,334 | — | $0 | 6,666 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-01-21 | 2026-01-23 | 3,334 | — | $0 | 43,548 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-09-12 | 2025-09-12 | 9,578 | $76.01 | $728.0K | 39,945 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-09-11 | 2025-09-12 | 18,333 | — | $0 | 18,333 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-09-11 | 2025-09-12 | 18,333 | — | $0 | 49,523 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-08-12 | 2025-08-12 | 2,954 | — | $0 | 29,046 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-08-12 | 2025-08-12 | 2,954 | $26.49 | $78.3K | 31,190 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-08-11 | 2025-08-12 | 8,000 | — | $0 | 28,236 | SEC↗ |
| MGX Metagenomi, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 8,572 | — | $0 | 8,572 | SEC↗ |
| CERS CERUS CORP | A Award | 2025-06-03 | 2025-06-04 | 60,000 | — | $0 | 222,133 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award deriv | 2025-05-14 | 2025-05-15 | 1,333 | — | $0 | 1,333 | SEC↗ |
| MGX Metagenomi, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-01-23 | 2025-01-27 | 2,667 | — | $0 | 5,333 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-01-23 | 2025-01-27 | 2,667 | — | $0 | 35,946 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-01-21 | 2025-01-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-01-21 | 2025-01-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CERS CERUS CORP | S Sale | 2024-12-12 | 2024-12-16 | 20,000 | $1.79 | $35.8K | 162,133 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2024-11-08 | 2024-11-14 | 475 | $21.05 | $10.0K | 33,279 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2024-09-11 | 2024-09-12 | 18,334 | — | $0 | 36,666 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2024-09-11 | 2024-09-12 | 18,334 | — | $0 | 32,804 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2024-08-27 | 2024-08-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award deriv | 2024-06-05 | 2024-06-06 | 1,333 | — | $0 | 1,333 | SEC↗ |
| CERS CERUS CORP | A Award | 2024-06-05 | 2024-06-06 | 40,000 | $5.00 | $200.0K | 182,133 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2024-05-10 | 2024-05-16 | 470 | $21.05 | $9.9K | 14,470 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2024-03-28 | 2024-04-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2024-03-27 | 2024-03-27 | 2,000 | $24.80 | $49.6K | 14,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2024-03-18 | 2024-03-18 | 2,000 | $25.80 | $51.6K | 12,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-01-23 | 2024-01-25 | 32,000 | — | $0 | 32,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-01-23 | 2024-01-25 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CERS CERUS CORP | P Buy | 2023-12-13 | 2023-12-13 | 10,000 | $1.62 | $16.2K | 142,133 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2023-09-11 | 2023-09-12 | 55,000 | — | $0 | 55,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2023-09-11 | 2023-09-12 | 110,000 | — | $0 | 110,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2023-09-11 | 2023-09-12 | 10,000 | $29.65 | $296.5K | 10,000 | SEC↗ |
| CERS CERUS CORP | P Buy | 2023-08-21 | 2023-08-23 | 10,000 | $1.72 | $17.2K | 132,133 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 2,435 | — | $0 | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 14,667 | — | $0 | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 21,000 | — | $0 | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 8,400 | — | $0 | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 16,415 | — | $0 | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 144,787 | $26.02 | $3.77M | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 21,501 | $24.86 | $534.5K | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 88,000 | $27.10 | $2.38M | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 84,000 | $14.73 | $1.24M | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer | 2023-08-11 | 2023-08-11 | 39,371 | — | $0 | 0 | SEC↗ |
| CERS CERUS CORP | A Award | 2023-06-07 | 2023-06-09 | 40,000 | $5.00 | $200.0K | 122,133 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-05-31 | 2023-06-01 | 150 | $4.20 | $630 | 3,684 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-05-31 | 2023-06-01 | 100 | $4.09 | $409 | 3,534 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-05-30 | 2023-06-01 | 5 | $3.25 | $16 | 3,434 | SEC↗ |
| CERS CERUS CORP | P Buy | 2023-05-23 | 2023-05-23 | 5,000 | $2.00 | $10.0K | 82,133 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-05-23 | 2023-05-24 | 500 | $3.27 | $1.6K | 3,429 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-05-19 | 2023-05-22 | 199 | $2.65 | $527 | 2,929 | SEC↗ |
| SRZN Surrozen, Inc./DE | A Award deriv | 2023-05-18 | 2023-05-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-05-18 | 2023-05-18 | 300 | $2.70 | $810 | 2,729 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-05-18 | 2023-05-22 | 1 | $2.65 | $3 | 2,730 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-05-17 | 2023-05-18 | 200 | $2.67 | $534 | 2,429 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2023-05-16 | 2023-05-18 | 800 | $2.70 | $2.2K | 2,229 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-05-08 | 2023-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GRAY CalciMedica, Inc. | D To issuer deriv | 2023-03-23 | 2023-03-27 | 1,429 | — | $0 | 0 | SEC↗ |
| GRAY CalciMedica, Inc. | D To issuer | 2023-03-23 | 2023-03-27 | 1,429 | — | $0 | 1,429 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise deriv | 2023-02-10 | 2023-02-15 | 2,435 | — | $0 | 2,435 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise | 2023-02-10 | 2023-02-15 | 2,435 | — | $0 | 39,724 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | S Sale | 2023-02-10 | 2023-02-15 | 857 | $23.75 | $20.4K | 38,867 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2023-01-31 | 2023-02-02 | 84,000 | — | $0 | 84,000 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise deriv | 2023-01-31 | 2023-02-02 | 7,333 | — | $0 | 14,667 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2023-01-31 | 2023-02-02 | 21,000 | — | $0 | 21,000 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | S Sale | 2023-01-31 | 2023-02-02 | 2,891 | $24.68 | $71.3K | 37,289 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise | 2023-01-31 | 2023-02-02 | 7,333 | — | $0 | 40,180 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | S Sale | 2022-12-01 | 2022-12-02 | 5,770 | $22.29 | $128.6K | 32,847 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise deriv | 2022-11-30 | 2022-12-02 | 16,414 | — | $0 | 16,415 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise | 2022-11-30 | 2022-12-02 | 16,414 | — | $0 | 38,617 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | A Award deriv | 2022-06-02 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | A Award deriv | 2022-06-02 | 2022-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2022-06-01 | 2022-06-03 | 39,866 | — | $0 | 39,866 | SEC↗ |
| CERS CERUS CORP | A Award | 2022-06-01 | 2022-06-03 | 20,454 | — | $0 | 77,133 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | S Sale | 2022-02-11 | 2022-02-14 | 895 | $12.74 | $11.4K | 22,203 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise deriv | 2022-02-10 | 2022-02-14 | 2,434 | — | $0 | 4,870 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise | 2022-02-10 | 2022-02-14 | 2,434 | — | $0 | 23,098 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2022-01-31 | 2022-02-02 | 22,000 | — | $0 | 22,000 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2022-01-31 | 2022-02-02 | 88,000 | — | $0 | 88,000 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise deriv | 2021-12-01 | 2021-12-03 | 16,414 | — | $0 | 32,829 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise | 2021-12-01 | 2021-12-03 | 16,414 | — | $0 | 26,414 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | F Tax w/h | 2021-12-01 | 2021-12-03 | 5,750 | $16.02 | $92.1K | 20,664 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2021-06-02 | 2021-06-03 | 29,983 | — | $0 | 29,983 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | A Award deriv | 2021-06-02 | 2021-06-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CERS CERUS CORP | A Award | 2021-06-02 | 2021-06-03 | 14,888 | — | $0 | 56,679 | SEC↗ |
| CERS CERUS CORP | M Exercise deriv | 2021-06-01 | 2021-06-03 | 13,228 | — | $0 | 0 | SEC↗ |
| CERS CERUS CORP | M Exercise | 2021-06-01 | 2021-06-03 | 13,228 | — | $0 | 41,791 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2021-02-10 | 2021-02-12 | 7,304 | — | $0 | 7,304 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2021-02-10 | 2021-02-12 | 21,501 | — | $0 | 21,501 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2020-11-30 | 2020-12-18 | 144,787 | — | $0 | 144,787 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2020-11-30 | 2020-12-18 | 49,243 | — | $0 | 49,243 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 56,250 | $10.69 | $601.3K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 78,750 | $10.78 | $848.9K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 56,250 | $0.43 | $24.2K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 264,800 | $15.06 | $3.99M | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer | 2020-10-13 | 2020-10-14 | 23,905 | $34.50 | $824.7K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | U Tender | 2020-10-10 | 2020-10-14 | 27,805 | $34.50 | $959.3K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise deriv | 2020-10-05 | 2020-10-05 | 5,200 | — | $0 | 264,800 | SEC↗ |
| CERS CERUS CORP | M Exercise deriv | 2020-10-05 | 2020-10-06 | 4,281 | — | $0 | 4,281 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | M Exercise | 2020-10-05 | 2020-10-05 | 5,200 | $19.44 | $101.1K | 49,841 | SEC↗ |
| CERS CERUS CORP | M Exercise | 2020-10-05 | 2020-10-06 | 4,281 | — | $0 | 28,563 | SEC↗ |
| GRAY GRAYBUG VISION, INC. | A Award deriv | 2020-09-24 | 2020-09-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | F Tax w/h | 2020-09-15 | 2020-09-16 | 840 | $34.25 | $28.8K | 44,547 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2020-06-03 | 2020-06-05 | 28,177 | — | $0 | 28,177 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2020-06-03 | 2020-06-05 | 13,228 | — | $0 | 13,228 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2020-05-10 | 2020-05-12 | 2,420 | — | $0 | 45,387 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2020-03-12 | 2020-03-12 | 1,000 | $15.10 | $15.1K | 42,967 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2020-03-09 | 2020-03-10 | 1,000 | $18.97 | $19.0K | 41,967 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | F Tax w/h | 2020-03-02 | 2020-03-04 | 1,982 | $23.81 | $47.2K | 40,967 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2020-02-28 | 2020-03-03 | 56,250 | — | $0 | 56,250 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2020-02-28 | 2020-03-03 | 9,375 | — | $0 | 42,949 | SEC↗ |
| CERS CERUS CORP | P Buy | 2020-01-29 | 2020-02-03 | 20,000 | $4.15 | $83.0K | 24,282 | SEC↗ |
| CERS CERUS CORP | M Exercise deriv | 2019-10-04 | 2019-10-04 | 4,282 | — | $0 | 8,562 | SEC↗ |
| CERS CERUS CORP | M Exercise | 2019-10-04 | 2019-10-04 | 4,282 | — | $0 | 4,282 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2019-09-18 | 2019-09-20 | 1,550 | $22.57 | $35.0K | 33,574 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2019-06-05 | 2019-06-07 | 11,184 | — | $0 | 11,184 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2019-06-05 | 2019-06-07 | 23,703 | — | $0 | 23,703 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2019-02-22 | 2019-02-26 | 78,750 | — | $0 | 78,750 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2019-02-22 | 2019-02-26 | 13,125 | — | $0 | 32,857 | SEC↗ |
| CORI Corium International, Inc. | D To issuer deriv | 2018-11-27 | 2018-11-28 | 20,000 | $12.50 | $250.0K | 0 | SEC↗ |
| CORI Corium International, Inc. | D To issuer deriv | 2018-11-27 | 2018-11-28 | 12,000 | $12.50 | $150.0K | 0 | SEC↗ |
| CORI Corium International, Inc. | D To issuer deriv | 2018-11-27 | 2018-11-28 | 15,000 | $12.50 | $187.5K | 0 | SEC↗ |
| CORI Corium International, Inc. | D To issuer deriv | 2018-11-27 | 2018-11-28 | 15,000 | $12.50 | $187.5K | 0 | SEC↗ |
| CORI Corium International, Inc. | D To issuer | 2018-11-27 | 2018-11-28 | 12,000 | $12.50 | $150.0K | 0 | SEC↗ |
| CORI Corium International, Inc. | D To issuer | 2018-11-27 | 2018-11-28 | 12,500 | $12.50 | $156.3K | 0 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2018-10-05 | 2018-10-09 | 12,844 | — | $0 | 12,844 | SEC↗ |
| CERS CERUS CORP | A Award deriv | 2018-10-05 | 2018-10-09 | 24,013 | — | $0 | 24,013 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2018-06-13 | 2018-06-14 | 1,600 | $30.41 | $48.7K | 19,485 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2018-03-04 | 2018-03-06 | 56,250 | — | $0 | 56,250 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2018-03-04 | 2018-03-06 | 9,375 | — | $0 | 17,500 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2018-02-26 | 2018-02-26 | 3,125 | $32.00 | $100.0K | 8,125 | SEC↗ |
| CORI Corium International, Inc. | A Award deriv | 2017-12-01 | 2017-12-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2017-05-12 | 2017-05-15 | 5,000 | $19.84 | $99.2K | 5,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2017-04-28 | 2017-05-01 | 270,000 | — | $0 | 270,000 | SEC↗ |
| CORI Corium International, Inc. | A Award deriv | 2016-12-22 | 2016-12-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2016-11-30 | 2016-12-02 | 95,000 | — | $0 | 95,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2016-11-30 | 2016-12-06 | 95,000 | — | $0 | 95,000 | SEC↗ |
| CORI Corium International, Inc. | P Buy | 2016-05-19 | 2016-05-20 | 6,341 | $3.70 | $23.5K | 12,000 | SEC↗ |
| CORI Corium International, Inc. | P Buy | 2016-05-19 | 2016-05-20 | 7,790 | $3.71 | $28.9K | 12,500 | SEC↗ |
| CORI Corium International, Inc. | P Buy | 2016-05-18 | 2016-05-20 | 5,659 | $3.57 | $20.2K | 5,659 | SEC↗ |
| CORI Corium International, Inc. | P Buy | 2016-05-18 | 2016-05-20 | 4,710 | $3.54 | $16.7K | 4,710 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award | 2016-02-29 | 2016-03-02 | 80,000 | — | $0 | 135,913 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | F Tax w/h | 2016-02-29 | 2016-03-02 | 34,991 | $0.75 | $26.2K | 100,922 | SEC↗ |
| STEM STEMCELLS INC | A Award | 2016-01-01 | 2016-01-05 | 146,342 | — | $0 | 273,759 | SEC↗ |
| CORI Corium International, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2015-11-30 | 2015-12-02 | 270,000 | — | $0 | 270,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise deriv | 2015-07-24 | 2015-07-28 | 5,551 | — | $0 | 0 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise deriv | 2015-07-24 | 2015-07-28 | 11,105 | — | $0 | 0 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2015-07-24 | 2015-07-28 | 2,119 | $3.46 | $7.3K | 83,827 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise | 2015-07-24 | 2015-07-28 | 5,551 | $1.32 | $7.3K | 85,946 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2015-07-24 | 2015-07-28 | 4,239 | $3.46 | $14.7K | 80,395 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise | 2015-07-24 | 2015-07-28 | 11,105 | $1.32 | $14.7K | 84,634 | SEC↗ |
| CORI Corium International, Inc. | A Award deriv | 2015-04-14 | 2015-04-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award | 2015-02-27 | 2015-03-02 | 17,642 | — | $0 | 57,636 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | F Tax w/h | 2015-02-27 | 2015-03-02 | 7,723 | $2.22 | $17.1K | 49,913 | SEC↗ |
| STEM STEMCELLS INC | A Award | 2015-01-01 | 2015-01-05 | 58,253 | — | $0 | 127,417 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2014-10-31 | 2014-11-03 | 140,000 | — | $0 | 140,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | M Exercise deriv | 2014-08-27 | 2014-08-29 | 10,000 | — | $0 | 115,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-27 | 2014-08-29 | 10,000 | $8.00 | $80.0K | 39,994 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | M Exercise | 2014-08-27 | 2014-08-29 | 10,000 | $1.74 | $17.4K | 49,994 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2014-02-28 | 2014-03-04 | 125,000 | — | $0 | 125,000 | SEC↗ |
| STEM STEMCELLS INC | A Award | 2014-01-01 | 2014-01-10 | 47,164 | — | $0 | 69,164 | SEC↗ |
| STEM STEMCELLS INC | A Award | 2013-03-01 | 2013-03-04 | 10,000 | — | $0 | 22,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2013-02-28 | 2013-03-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | F Tax w/h | 2013-02-28 | 2013-03-01 | 2,599 | $5.22 | $13.6K | 33,994 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award | 2013-02-28 | 2013-03-01 | 7,088 | — | $0 | 36,593 | SEC↗ |
| STEM STEMCELLS INC | A Award | 2012-04-18 | 2012-04-20 | 9,000 | — | $0 | 12,000 | SEC↗ |
| STEM STEMCELLS INC | A Award | 2012-03-01 | 2012-03-02 | 1,000 | — | $0 | 3,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award deriv | 2012-02-29 | 2012-03-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | A Award | 2012-02-29 | 2012-03-02 | 17,349 | — | $0 | 32,222 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | F Tax w/h | 2012-02-29 | 2012-03-02 | 6,363 | $1.74 | $11.1K | 25,859 | SEC↗ |